somatostatin	No medication was given to the control group	Postoperative complications	9923	10088	Initially, 6 of 35 (17%) in the treated group who received somatostatin developed complications, whereas 18 of 32 (56%) in the control group developed complications.
somatostatin	No medication was given to the control group	Postoperative complications	743	876	Administration of somatostatin reduced the exocrine granule number, and the patients suffered from fewer postoperative complications.
